Cargando…
Study of the Relationship between HPA-1 and HPA-5 Gene Polymorphisms and Refractory to Platelet Therapy and Recombinant Factor VII in Glanzmann Thrombasthenia Patients in Southeast of Iran
Background: Glanzmann Thrombasthenia (GT) is a rare autosomal disease. HPA (Human Platelet Alloantigen) is a surface polymorphic alloantigen of platelets. This study was intended to investigate and compare the polymorphism of HPA-1 and HPA-5 genes in two groups of GT patients, with and without resis...
Autores principales: | Naderi, Majid, Habibpour, Manizheh, Alizadeh, Shaban, Kashani Khatib, Zahra, Dorgalaleh, Akbar, Issah, Mohammed Awal, Naadali, Fatemeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018251/ https://www.ncbi.nlm.nih.gov/pubmed/29951177 |
Ejemplares similares
-
Glanzmann thrombasthenia
por: Nurden, Alan T
Publicado: (2006) -
The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia
por: Poon, Man-Chiu
Publicado: (2021) -
Public Health Problems related to factor V deficiency in southeast of Iran
por: Naderi, Majid, et al.
Publicado: (2014) -
Glanzmann’s thrombasthenia and molecular mimicry
por: Wiwanitkit, Viroj
Publicado: (2010) -
Disease Burden in Patients with Glanzmann’s Thrombasthenia: Perspectives from the Glanzmann’s Thrombasthenia Patient/Caregiver Questionnaire
por: Duncan, Alexander, et al.
Publicado: (2020)